News

Astrea name change PR_Final

Albupure is an affinity adsorbent specifically developed for the purification of Albumin Fusion proteins

Issue link: https://www.astreabioseparations.com/resources/i/1200606

Contents of this Issue

Navigation

Page 0 of 0

PRESS RELEASE PROMETIC BIOSEPARATIONS TO BECOME ASTREA BIOSEPARATIONS LTD • Astrea Bioseparations will be the new name for Prometic Bioseparations Ltd • New branding and website launching – https://www.astreabioseparations.com Ballasalla, Isle of Man, British Isles and Cambridge, UK – January 14th, 2020 – Prometic Bioseparations Ltd announced today that it is changing its name to Astrea Bioseparations Ltd. "This name change follows our recent divestment from Liminal Biosciences Inc. (formerly Prometic Life Sciences Inc.) to Gamma Biosciences, a life sciences tools platform supported by KKR, and reflects a re-focusing of the business on our proven ability to develop and commercialise high-quality selective adsorbents which are used increasingly by the biomanufacturing industry to purify a wide range of advanced biological products" said Dr. Steve Burton, CEO of Astrea. "Astrea Bioseparations is the only bioseparations company to offer ligand discovery and adsorbent development services in combination with large-scale manufacture of chromatography adsorbents and production of pre-packed chromatography columns to GMP standards" Dr. Burton added. Along with the new name a new website will also be launched, to discover more please visit https://www.astreabioseparations.com About Astrea Bioseparations Ltd. Astrea Bioseparations Ltd. (formerly Prometic Bioseparations Ltd) is a bioseparations company specializing in the research, development, manufacture and marketing of bioseparation products including chromatography adsorbents and pre-packed chromatography columns. A wholly owned subsidiary of Gamma Biosciences, a life sciences tools platform supported by KKR, Astrea Bioseparations has R&D laboratories located at Cambridge, UK and manufacturing facilities located at the Isle of Man, British Isles and Joliette, Quebec, Canada. ### For further information please contact: Steve Burton Andy Davies CEO Sales and Marketing Director [email protected] [email protected]

Articles in this issue

Links on this page

Archives of this issue

view archives of News - Astrea name change PR_Final